Literature DB >> 28716623

A 'second truncation' in TTN causes early onset recessive muscular dystrophy.

Elizabeth Harris1, Ana Töpf1, Anna Vihola2, Anni Evilä2, Rita Barresi3, Judith Hudson4, Peter Hackman2, Brian Herron5, Daniel MacArthur6, Hanns Lochmüller1, Kate Bushby1, Bjarne Udd7, Volker Straub8.   

Abstract

Mutations in the gene encoding the giant skeletal muscle protein titin are associated with a variety of muscle disorders, including recessive congenital myopathies ±cardiomyopathy, limb girdle muscular dystrophy (LGMD) and late onset dominant distal myopathy. Heterozygous truncating mutations have also been linked to dilated cardiomyopathy. The phenotypic spectrum of titinopathies is emerging and expanding, as next generation sequencing techniques make this large gene amenable to sequencing. We undertook whole exome sequencing in four individuals with LGMD. An essential splice site mutation, previously reported in dilated cardiomyopathy, was identified in all families in combination with a second truncating mutation. Affected individuals presented with childhood onset proximal weakness associated with joint contractures and elevated CK. Cardiac dysfunction was present in two individuals. Muscle biopsy showed increased internal nuclei and immunoblotting identified reduction or absence of calpain-3 and demonstrated a marked reduction of C-terminal titin fragments. We confirm the co-occurrence of cardiac and skeletal myopathies associated with recessive truncating titin mutations. Compound heterozygosity of a truncating mutation previously associated with dilated cardiomyopathy and a 'second truncation' in TTN was identified as causative in our skeletal myopathy patients. These findings add to the complexity of interpretation and genetic counselling for titin mutations.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dilated cardiomyopathy; Exome sequencing; Limb girdle muscular dystrophy; Titin; Titinopathy

Mesh:

Substances:

Year:  2017        PMID: 28716623     DOI: 10.1016/j.nmd.2017.06.013

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  6 in total

1.  Novel compound heterozygous mutations in the TTN gene: elongation and truncation variants causing limb-girdle muscular dystrophy type 2J in a Han Chinese family.

Authors:  Guangyu Wang; Xiaoqing Lv; Ling Xu; Rui Zhang; Chuanzhu Yan; Pengfei Lin
Journal:  Neurol Sci       Date:  2022-03-03       Impact factor: 3.830

Review 2.  The Complex and Diverse Genetic Architecture of Dilated Cardiomyopathy.

Authors:  Ray E Hershberger; Jason Cowan; Elizabeth Jordan; Daniel D Kinnamon
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

3.  Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy.

Authors:  Elizabeth Harris; Ana Topf; Rita Barresi; Judith Hudson; Helen Powell; James Tellez; Debbie Hicks; Anna Porter; Marta Bertoli; Teresinha Evangelista; Chiara Marini-Betollo; Ólafur Magnússon; Monkol Lek; Daniel MacArthur; Kate Bushby; Hanns Lochmüller; Volker Straub
Journal:  Orphanet J Rare Dis       Date:  2017-09-06       Impact factor: 4.123

4.  Takotsubo as Initial Manifestation of Non-Myopathic Cardiomyopathy Due to the Titin Variant c.1489G > T.

Authors:  Hans Keller; Ulrike Neuhold; Franz Weidinger; Edmund Gatterer; Claudia Stöllberger; Klaus Huber; Josef Finsterer
Journal:  Medicines (Basel)       Date:  2018-07-30

5.  Childhood onset limb-girdle muscular dystrophies in the Aegean part of Turkey.

Authors:  Uluç Yiş; Gülden Diniz; Filiz Hazan; Hülya Sevcan Daimagüler; Bahar Toklu Baysal; Figen Baydan; Gülçin Akinci; Aycan Ünalp; Gül Aktan; Erhan Bayram; Semra Hiz; Cem Paketçi; Derya Okur; Erdener Özer; Ayça Ersen Danyeli; Muzaffer Polat; Gökhan Uyanik; Sebahattin Çirak
Journal:  Acta Myol       Date:  2018-09-01

6.  Two novel mutations in TTN of a patient with congenital myopathy: A case report.

Authors:  Joon Young Jang; Yulhyun Park; Dae-Hyun Jang; Ja-Hyun Jang; Ju Seok Ryu
Journal:  Mol Genet Genomic Med       Date:  2019-07-22       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.